NeoHack Secures Patent for 'Compositions and Methods of Achieving Pain Relief"
Doctor Brown Explains
The Science of "Pain Management"
Anyone will tell you that the science of "pain management" in the last two decades has been fraught with miscalculations, missteps and outright abuses. It has largely produced only what it says: management. Believing that management was not enough, NeoHack set out to learn new sources of relief and better systemic applications from the best teacher of all -- nature. Read on to learn what we found.
A Better Way
A wide variety of inflammatory conditions such as chronic and neuropathic pain and itch are caused by "non-homeostasis", or an imbalance in the body's natural response to injury, structural change, etc. NeoHack has developed a patent-pending "synergistic formulation" from natural and nature-identical ingredients that work directly on "ionotropic cannabinoid receptors", moving the needle on returning the body to homeostasis, or its ideal "set point". By treating pain at this source, patients using NeoHack's formulation state that they found longer-lasting relief from-- or at times, a non-recurrence of -- conditions they sought to treat. In some cases, the formulation also worked on conditions they weren't seeking to treat.
A Safer Way
NeoHack uses the skin as a vehicle for administering its non-opioid formulation, thereby avoiding the troublesome side effects of oral opioids such as addiction, nausea, mental changes, phantom itching and persistent constipation.
A Patent-Pending Discovery
NeoHack strategically combines a number of natural and nature-identical ingredients -- each with valuable properties -- in a way that causes the resulting product to perform at a higher level against conditions -- and in ways that each stand-alone ingredient cannot. You can inspect the relevant patents on this site to learn more..
Case Studies and User Testimony from the Pending Patents
Actual case studies of patient successes using NeoHack's formulation have been recorded on this site under the "Case Studies" tab, in addition to being included in the pending patent.